Understanding CPT Code 98928: Belimumab Administration for SLE

Medical code 98928 is a Current Procedural Terminology (CPT) code used in medical billing and coding to describe the administration of certain prescription drugs. It is specifically used to report the administration of the drug belimumab (Benlysta) for the treatment of systemic lupus erythematosus (SLE).

Belimumab is a human monoclonal antibody medication used to treat SLE, an autoimmune disease that causes inflammation and damage to the joints, skin, kidneys, and other organs. It is administered intravenously (IV) by a healthcare professional, usually in a clinical setting.

Medical code 98928 includes the administration of belimumab, as well as any related services or supplies needed for the procedure. This may include the preparation and administration of the drug, monitoring of the patient's vital signs, and providing any necessary patient education or instructions.

The use of medical code 98928 is important for accurate billing and reimbursement for the administration of belimumab. It allows healthcare providers to communicate with insurance companies and other payers about the specific services provided, ensuring that they receive appropriate reimbursement for their services.